Currently, important delays have been reported in diagnosing amyloid heart disease, perhaps not unexpectedly given the wide spectrum of possible clinical presentations. Beyond evaluating the typical clinical indicators to attain the correct diagnosis, healthcare practitioners need to be aware of diagnostic testing approaches which include screening for serum and urine free monoclonal light chains, echocardiography, bone scintigraphy, cardiac MRI and genetic sequencing. This podcast will focus on multimodality cardiac imaging approaches and the application of diagnostic findings which contribute to an accurate diagnosis of ATTR-CM, specifically in differentiating ATTR-CA from AL-CA, and how to determine treatment options.

Claim CE and MOC at https://bit.ly/ATTR-CM_series